News

Dr Henney has been one of the leaders and founders of the US biotechnology industry since 1980. Dr Henney co-founded three publicly held US biotechnology companies: Immunex Corporation

This agreement brings together two innovative technologies: Seegene’s dual priming oligo (DPO) multiplex polymerase chain reaction technology and Randox’s biochip array technology. This combination facilitates highly sensitive and

According to the company, the CollaRx lidocaine sponge is a lyophilized collagen sponge containing purified type-I collagen protein and lidocaine, a locally acting anesthetic. The product is intended

Fred Middleton, chairman and acting CEO of Novocell, said: “This composition patent is a milestone achievement for Novocell and is the culmination of extensive research that opened the

Between 2005 and 2015, the committee is tasked with allocating approximately $100 million in order to encourage stem cell research in Connecticut. “The possibilities for health care therapies

Amicas will offer its image management solutions to the Australian marketplace through an exclusive distribution partnership with Healthinc. The Amicas solution suite will be tightly integrated with Healthinc’s

Pharmasset has filed an investigational new drug application with the FDA earlier in this quarter of 2009. Michelle Berrey, chief medical officer of Pharmasset, said: “This is a

Most recently, Mr Landau has served as vice president of business development and marketing planning and member of the senior management team at Tengion, a regenerative medicine company.

US-based biotechnology company Oxygen Biotherapeutics has added clinical trial sites in Israel for the planned Phase II dose escalation study of Oxycyte in traumatic brain injury. Oxycyte is